Generate a tailored SOP for Dr. Ken Redekop. Improve your application with a focused, well-structured draft.
Ken Redekop, Ph.D. is an associate professor at the Institute of Medical Technology Assessment at Erasmus University Rotterdam, Netherlands. With over 20 years of experience as a clinical epidemiologist, he has extensively contributed to observational research and clinical trial analysis, focusing on medical technology assessment. Redekop has authored approximately 100 papers in medical literature. His current research interests include early-stage cost-effectiveness analyses of medical devices, randomized controlled trial (RCT)-based economic evaluations, and health technology assessment outcomes for the National Institute for Health and Care Excellence (NICE) in the UK. His studies primarily relate to diabetes, cardiovascular diseases, and cancer, involving advanced modeling and evidence synthesis techniques to evaluate the effectiveness and cost-effectiveness of expensive medicines in daily practice.
Department of Econometrics / MSc Econometrics and Management Science.